查詢結果分析
來源資料
相關文獻
- Hemoglobin Variability Does not Predict Mortality in Peritoneal Dialysis Patients
- 紅血球生成素1998
- The Effect of Recombinant Human Erythropoietin in Treating the Anemia of Prematurity
- The Clinical Experience of Higher rHuEPO Dosage in Chronic Hemodialysis Patients with Epo-Hyporesponsiveness
- Serum Transferrin Receptor is a Good Index of Erythropoietin Treatment in ESRD
- Assessment of Serum Erythropoietin Level in Chronic Hemodialysis Patients
- 降低血液透析病患紅血球生成素使用之改善專案
- The Response to Erythropoietin in Hemodialysis Patients with Thalassemia Diagnosed by Genomic DNA Analysis
- The Early Use of Recombinant Human Erythropoietin in Anemia of Prematurity
- 惡性腫瘤相關性貧血及紅血球生成素的臨床應用
頁籤選單縮合
題 名 | Hemoglobin Variability Does not Predict Mortality in Peritoneal Dialysis Patients=血紅素變化無法預測腹膜透析病人的死亡率 |
---|---|
作 者 | 陳河卿; 陳冠興; 林育志; 張啟仁; 田亞中; 楊智偉; 洪振傑; | 書刊名 | 長庚醫誌 |
卷 期 | 35:1 2012.01-02[民101.01-02] |
頁 次 | 頁79-87 |
分類號 | 415.816 |
關鍵詞 | 貧血; 紅血球生成素; 血色素變化; 死亡率; 腹膜透析; Anemia; Erythropoiesis-stimulating agent; Hemoglobin variability; Mortality; Peritoneal dialysis; |
語 文 | 英文(English) |
英文摘要 | Background: Hemoglobin variability in hemodialysis patients treated with erythropoiesisstimulating agents has been used to evaluate mortality and comorbidity. Different outcomes have been reported in American and European hemodialysis patients. There are, however, few studies of the effects of hemoglobin variability in peritoneal dialysis patients. Methods: We investigated hemoglobin variability in 363 peritoneal dialysis patients over 2 years to evaluate mortality and the association with comorbidity, peritonitis, and hospitalization. The hemoglobin of all patients selected for the study had been monitored for at least 6 months (April 2008 to September 2008). We assessed hemoglobin variability as fluctuations from the target hemoglobin level (11–12.5 g/dL). We defined the following 6 patient groups on the basis of hemoglobin patterns: consistently low (< 11 g/dL), consistently target range (11–12.5 g/dL), consistently high (> 12.5 g/dL), low-amplitude fluctuation with low hemoglobin levels, low-amplitude fluctuation with high hemoglobin levels, and high amplitude fluctuation. Results: Only 2% of patients maintained a stable hemoglobin level within the target range and 46.8% of patients exhibited consistently low hemoglobin levels. After 2 years of observation, there was no difference in mortality as assessed by Kaplan–Meier analysis. There were also no differences in peritonitis and hospitalization between the 6 groups. However, the length of hospital stay was longer in the high amplitude fluctuation group (p = 0.008). Conclusion: Hemoglobin variability does not predict mortality in peritoneal dialysis patients. |
本系統中英文摘要資訊取自各篇刊載內容。